SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Baxter International (BAX)
BAX 21.06+1.8%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Lee who wrote (82)10/23/2000 9:17:17 PM
From: Smartypts  Read Replies (1) of 101
 
Ok got it and here it is: Baxter sold the system (Isolex) to Nexell Theraputics, Inc., It was originally CellPro's. In July 1999 the FDA approved the company's Isolex system which was a mirror image of CellPro's. Baxter won the court case and CelPro patents were turned over to Baxter which came out with the devise called Isolex which they sold to Nexell. Now Nexell stock price is very depressed, however I would keep an eye on the research as the "machine" for seperating cancerous cells from normal cells might be very promising.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News